OYRELBI Trademark

Trademark Overview


On Monday, October 5, 2020, a trademark application was filed for OYRELBI with the United States Patent and Trademark Office. The USPTO has given the OYRELBI trademark a serial number of 90236326. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, August 20, 2021. This trademark is owned by ADC Therapeutics SA. The OYRELBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals
oyrelbi

General Information


Serial Number90236326
Word MarkOYRELBI
Filing DateMonday, October 5, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, August 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events


Event DateEvent Description
Friday, August 20, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, August 20, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, February 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 6, 2021NON-FINAL ACTION E-MAILED
Saturday, February 6, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2021ASSIGNED TO EXAMINER
Thursday, November 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 8, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords


oyrelbi pharmaceuticals